Impact of IFNα2b upon pSTAT3 and the MEK/ERK MAPK Pathway in Melanoma

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2008-04-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00262-008-0466-9PMID 18386001PMCID PMC11030104
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of Signal Transducers and Activators of Transcription 1 and 3 Signaling in Melanoma by High-Dose IFNα2b

  2007cited by this paper
• STAT3 as a central mediator of neoplastic cellular transformation.

  2007cited by this paper
• The Src signaling pathway: a potential target in melanoma and other malignancies

  2007cited by this paper
• BRAF somatic mutations in malignant melanoma and melanocytic naevi

  2006cited by this paper
• Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses.

  2006influential reference
• Activation of stat3 in human melanoma promotes brain metastasis.

  2006cited by this paper
• BCR–ABL activates STAT3 via JAK and MEK pathways in human cells

  2006cited by this paper
• Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells

  2006cited by this paper
• Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis

  2006cited by this paper
• Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.

  2006cited by this paper
• Touched and Moved by STAT3

  2006cited by this paper
• Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation.

  2005cited by this paper
• Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer

  2005cited by this paper
• Targeting STAT3 affects melanoma on multiple fronts

  2005cited by this paper
• RKIP downregulates B-Raf kinase activity in melanoma cancer cells

  2005cited by this paper
• Recent advances on T-cell regulation by receptor tyrosine kinases

  2005cited by this paper
• MAP kinases in immune responses.

  2005cited by this paper
• Rapid inhibition of MAPK signaling and anti-proliferation effect via JAK/STAT signaling by interferon-alpha in hepatocellular carcinoma cell lines.

  2005cited by this paper
• Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells.

  2004cited by this paper
• Inactivation of Stat3 in tumor cells: releasing a brake on immune responses against cancer?

  2004cited by this paper
• A Pooled Analysis of Eastern Cooperative Oncology Group and Intergroup Trials of Adjuvant High-Dose Interferon for Melanoma

  2004cited by this paper
• Protein Kinases and Phosphatases: The Yin and Yang of Protein Phosphorylation and Signaling Review

  2004cited by this paper
• The STATs of cancer — new molecular targets come of age

  2004cited by this paper
• Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells

  2003cited by this paper
• ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility.

  2003cited by this paper
• Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

  2002cited by this paper
• Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.

  2002cited by this paper
• MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b.

  2002cited by this paper
• A view to a kill: signals triggering cytotoxicity.

  2002cited by this paper
• Roles of activated Src and Stat3 signaling in melanoma tumor cell growth

  2002cited by this paper
• Duration of calcineurin and Erk signals regulates CD4/CD8 lineage commitment of thymocytes.

  2002cited by this paper
• Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis

  2002cited by this paper
• MEK and ERK inhibitors enhance the antiproliferative effect of interferon‐α2b

  2002cited by this paper
• High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801.

  2001cited by this paper
• STAT1 Affects Lymphocyte Survival and Proliferation Partially Independent of Its Role Downstream of IFN-γ1

  2000cited by this paper
• Activation-Induced Inhibition of Interleukin 6–Mediated T Cell Survival and Signal Transducer and Activator of Transcription 1 Signaling

  2000cited by this paper
• Signaling pathways in Ras-mediated tumorigenicity and metastasis.

  1998cited by this paper
• Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

  1996cited by this paper
• Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling.

  1995cited by this paper
• Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

  1995cited by this paper
• Transcriptional regulation by extracellular signals: mechanisms and specificity.

  1995cited by this paper
• Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells.

  1994cited by this paper

• Genistein alleviates doxorubicin‐induced cardiomyocyte autophagy and apoptosis via ERK/STAT3/c‐Myc signaling pathway in rat model

  2024cites this paper
• Chikusetsusaponin Iva induces apoptosis and inhibits proliferation in endometrial cancer via promoting reactive oxygen species (ROS) production

  2023cites this paper
• Isoamylamine Induces B16-F1 Melanoma Cell Autophagy by Upregulating the 5′ Adenosine Monophosphate-Activated Protein Pathway

  2021cites this paper
• The Role of miRNAs in Zearalenone-Promotion of TM3 Cell Proliferation

  2019cites this paper
• MicroRNA‐23a inhibits melanoma cell proliferation, migration, and invasion in mice through a negative feedback regulation of sdcbp and the MAPK/ERK signaling pathway

  2018cites this paper
• Unveil the mysterious mask of cytokine-based immunotherapy for melanoma.

  2017cites this paper
• Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma

  2016cites this paper
• Risk Reductions of Recurrence and Mortality in Melanoma Patients Using IFN-α

  2016cites this paper
• The use of interferon in melanoma patients: a systematic review.

  2015cites this paper
• Neoadjuvant therapy for melanoma: a promising therapeutic approach and an ideal platform in drug development.

  2015cites this paper
• IL28B Polymorphism Cannot Predict Response to Interferon Alpha Treatment in Patients with Melanoma

  2014cites this paper
• STAT3 and Src Signaling in Melanoma

  2012cites this paper
• Update on PEG-interferon α-2b as adjuvant therapy in melanoma.

  2012cites this paper
• Potential for Modulation of the Fas Apoptotic Pathway by Epidermal Growth Factor in Sarcomas

  2011cites this paper
• Adjuvant Therapy: Melanoma

  2011cites this paper
• Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562.

  2010cites this paper
• Potential for functional redundancy in EGF and TGFα signaling in desmoid cells: a cDNA microarray analysis

  2010cites this paper
• Cutaneous Melanoma: A Test Field for Immunotherapy and a Medical Challenge

  2010cites this paper
• Where are we with adjuvant therapy of stage III and IV melanoma in 2009?

  2009cites this paper
• A Novel Approach for the Treatment of Pancreatic Cancer

  2009cites this paper
• Quimiorresistencia del melanoma

  2009cites this paper
• Chemoresistance to melanoma

  2009cites this paper
• Biomarkers of therapeutic response in melanoma and renal cell carcinoma: potential inroads to improved immunotherapy.

  2009cites this paper
• Adjuvant Therapy of Melanoma

  2007cites this paper
• World Journal of Hepatology

  year unknowncites this paper